Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 50, 2020 - Issue 24
279
Views
7
CrossRef citations to date
0
Altmetric
Articles

Synthesis of 2,5-disubstituted-1,3,4-thiadiazole derivatives from (2S)-3-(benzyloxy)-2-[(tert-butoxycarbonyl) amino] propanoic acid and evaluation of anti-microbial activity

ORCID Icon, , , & ORCID Icon
Pages 3854-3864 | Received 03 Jul 2020, Published online: 11 Sep 2020
 

Abstract

The new compounds AP-1 to AP-10 were synthesized from starting material (2S)-3-(benzyloxy)-2-[(tert-butoxycarbonyl) amino]propanoic acid (1). The intermediate 2,5-disubstituted-1,3,4-thiadiazole amine (5) was prepared by coupling of (2S)-3-(Benzyloxy)-2-[(tert-butoxycarbonyl) amino]propanoic acid (1) with pyridine-2-carboxylic acid hydrazide (2) in the presence of carbonyldiimidazole (CDI) followed by 1,3,4-thiadiazole ring formation via diacylhydrazines derivative (3) and deprotection with shorter reaction time and excellent yield. The structures of new compounds were confirmed by spectral analysis. The series of new synthesized compounds AP-1 to AP-10 were evaluated for their anti-microbial activities in vitro and compounds AP-1, AP-3, AP-4, and AP-10 showed strong activities against all tested microorganisms.

Graphical Abstract

Acknowledgments

The authors gratefully acknowledge the Director, UGC, WRO Pune for providing financial assistance and thankful to Principal, Shivaji Arts, Commerce and Science College Kannad, District Aurangabad (M.S.) for providing research laboratory facilities. The authors are grateful to Dr. Arvind Merwade, AVP of Wockhardt Research Centre, Aurangabad and Dr. Dinanath Deoram Patil, Principal, Sahakar Maharshi Bhausaheb Santuji Thorat Arts, Science and Commerce College, Sangamner for motivation and kind support during work.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.